ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,642Medicare Part D Prescriptions Filled, Including Refills

Rank: 589 out of 3734

$681K Total Retail Price of All Prescriptions

Rank: 340 out of 3734

133 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 133 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,211 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

73 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 325 301 1 5
METOPROLOL TARTRATE 321 285 2 6
OMEPRAZOLE 277 262 3 4
HYDROCHLOROTHIAZIDE 274 266 4 9
LOVAZA 264 262 5 143
FUROSEMIDE 252 251 6 7
ATORVASTATIN CALCIUM 252 238 6 11
ZOLPIDEM TARTRATE 239 229 8 24
DIOVAN 203 192 9 31
LIPITOR 188 188 10 90
MECLIZINE HCL 176 176 11 139
LEVOTHYROXINE SODIUM 163 140 12 2
PLAVIX 160 160 13 39
METOPROLOL SUCCINATE 160 156 13 14
GLIPIZIDE XL 154 146 15 85
METFORMIN HCL 153 140 16 8
SYNTHROID 152 152 17 47
LIDODERM 152 151 17 170
CLONIDINE HCL 149 148 19 79
SINGULAIR 138 138 20 95
LISINOPRIL 138 130 20 3
FLUTICASONE PROPIONATE 123 123 22 46
JANUVIA 118 118 23 50
ISOSORBIDE MONONITRATE ER 110 110 24 34
RANEXA 108 108 25 407
CRESTOR 106 106 26 28
EXFORGE 106 105 26 183
ATENOLOL 101 101 28 13
RANITIDINE HCL 94 90 29 32
CLOPIDOGREL 90 90 30 23
SIMVASTATIN 86 80 31 1
NITROSTAT 85 85 32 237
AMLODIPINE BESYLATE-BENAZEPRIL 85 85 32 56
IBUPROFEN 82 81 34 75
SINGLE USE SWAB 81 79 35 292
NASONEX 79 79 36 239
SERTRALINE HCL 78 67 37 18
ALLOPURINOL 78 78 37 33
DOXAZOSIN MESYLATE 77 77 39 100
CREON 75 75 40 495
CARVEDILOL 73 73 41 30
GLIPIZIDE ER 72 70 42 119
ALENDRONATE SODIUM 72 72 42 26
HYDROCORTISONE 67 67 44 217
NEXIUM 63 61 45 36
GABAPENTIN 63 63 45 17
PROCTOZONE-HC 58 58 47 438
FINASTERIDE 57 47 48 88
ADVAIR DISKUS 52 52 49 35
MONTELUKAST SODIUM 52 49 49 175
PANTOPRAZOLE SODIUM 51 51 51 22
POTASSIUM CHLORIDE 51 51 51 19
LANSOPRAZOLE 50 48 53 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.